NCT00487513
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
NCT00487513
NCT00143845
NCT00408681
NCT00461500
Not specified
NCT03069248
NCT00413036
NCT01809600
NCT02435108
NCT03054883
Not specified
NCT01089322